The bill meaningfully expands price transparency and patient protections (binding estimates, itemized bills, public machine‑readable price files, and stronger enforcement), improving consumers' ability to shop and dispute charges, but it does so at the cost of substantial compliance burdens, privacy risks, enforcement exposure, and potential downstream price or access impacts—especially for smaller and rural providers.
Patients (including low‑income, Medicaid, Medicare, and chronically ill individuals) face fewer surprise charges because providers must give plain‑language, itemized good‑faith estimates and EOBs that are binding unless unforeseeable medical necessity is documented.
Consumers (patients, employers, and cash‑paying individuals) gain broad price transparency across hospitals, labs, imaging centers, ASCs, and health plans—payer‑specific negotiated rates, discounted cash prices, and machine‑readable files—making it easier to compare costs and shop for lower‑cost care.
Federal agencies (HHS, DOL) and regulators have funding, standardized formats, and enforcement authority (including attestations and ownership disclosures) to hold hospitals, labs, plans, and vendors accountable for accurate price and ownership information.
Hospitals, labs, imaging centers, ASCs, health plans, PBMs, TPAs, and smaller providers face substantial ongoing compliance, IT, and administrative costs to generate itemized bills, machine‑readable files, attestations, and real‑time tools—costs that are likely to be passed to patients, employers, or taxpayers via higher prices or premiums.
Large daily civil monetary penalties and aggressive enforcement exposure create financial risk—particularly for smaller and rural providers and labs—which may prompt conservative billing/pricing behavior, deter service offerings, or reduce local availability of care.
Expanded requirements to include detailed PHI, provider identifiers, payer names, and machine‑readable transaction data increase privacy and data‑security risks if de‑identification or safeguards are imperfect, potentially exposing sensitive patient information.
Based on analysis of 13 sections of legislative text.
Mandates broad price transparency, universal good‑faith estimates and itemized bills, stronger patient billing protections, and robust data access requirements for plans and regulators.
Official title: Amend the Public Health Service Act to provide for hospital and insurer price transparency.
Introduced July 17, 2025 by Roger Wayne Marshall · Last progress July 17, 2025
Requires broad price transparency by hospitals, labs, imaging providers, ambulatory surgical centers, insurers, and health-plan service providers and gives patients stronger billing and itemized‑billing rights. Establishes machine‑readable and consumer‑friendly public files of prices and negotiated rates, requires advance and post‑service itemized explanations of benefits and good‑faith estimates, bars many surprise or substantially higher bills, and creates civil penalties and enforcement duties for HHS, Labor, and Treasury. Sets uniform publication formats, mandated attestations by senior officials, annual compliance reviews, and rulemaking deadlines; authorizes ongoing funding to implement and enforce the law. Many provisions take effect for plan years or calendar years beginning one year after enactment and require notice‑and‑comment rulemaking to define standards and thresholds.